We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

325 hedge funds and large institutions have $8.58B invested in Jazz Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 107 increasing their positions, 118 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 44

14% more capital invested

Capital invested by funds: $7.51B → $8.58B (+$1.07B)

7% more funds holding

Funds holding: 305 → 325 (+20)

0% more funds holding in top 10

Funds holding in top 10: 12 → 12 (0)

9% less repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 118

48% less call options, than puts

Call options by funds: $137M | Put options by funds: $261M

Holders
325
Holders Change
+20
Holders Change %
+6.56%
% of All Funds
9.43%
Holding in Top 10
12
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.35%
New
65
Increased
107
Reduced
118
Closed
44
Calls
$137M
Puts
$261M
Net Calls
-$125M
Net Calls Change
-$102M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$417M
2
CM
Churchill Management
California
+$50.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$40.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$39.5M
5
Invesco
Invesco
Georgia
+$38.1M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$50.7M
2
PC
PointState Capital
New York
-$50M
3
Jennison Associates
Jennison Associates
New York
-$49.9M
4
LPC
Lone Pine Capital
Connecticut
-$45.9M
5
HM
HealthCor Management
New York
-$40.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCBA
151
Weaver C. Barksdale & Associates
Tennessee
$2.49M +$2.38M +15,500 New
Public Employees Retirement Association of Colorado
152
Public Employees Retirement Association of Colorado
Colorado
$2.48M -$2.77K -18 -0.1%
GL
153
GLG LLC
New York
$2.44M – – –
Comerica Bank
154
Comerica Bank
Texas
$2.39M -$666K -4,331 -23%
HNB
155
Huntington National Bank
Ohio
$2.35M +$170K +1,106 +8%
GC
156
Guggenheim Capital
Illinois
$2.31M -$78.4K -510 -3%
ACM
157
Atika Capital Management
New York
$2.25M +$2.15M +14,000 New
IRF
158
IBM Retirement Fund
New York
$2.19M -$41.4K -269 -2%
OAM
159
Oxford Asset Management
United Kingdom
$2.18M -$1.38M -8,953 -40%
HighTower Advisors
160
HighTower Advisors
Illinois
$2.09M -$890K -5,788 -31%
VRS
161
Virginia Retirement Systems
Virginia
$1.98M -$15.4K -100 -0.8%
DCM
162
Driehaus Capital Management
Illinois
$1.92M -$1.81M -11,763 -50%
DCM
163
Dupont Capital Management
Delaware
$1.85M -$369K -2,397 -17%
PP
164
Paloma Partners
Connecticut
$1.83M +$1.75M +11,400 New
Mackenzie Financial
165
Mackenzie Financial
Ontario, Canada
$1.81M +$1.74M +11,300 New
TD Asset Management
166
TD Asset Management
Ontario, Canada
$1.8M -$538K -3,500 -24%
Nomura Holdings
167
Nomura Holdings
Japan
$1.77M +$56.6K +368 +3%
KBC Group
168
KBC Group
Belgium
$1.76M -$7.65M -49,782 -82%
AssetMark Inc
169
AssetMark Inc
California
$1.75M +$1.67M +10,884 New
SCM
170
Sterling Capital Management
North Carolina
$1.74M +$246K +1,600 +17%
Royal Bank of Canada
171
Royal Bank of Canada
Ontario, Canada
$1.69M -$290K -1,887 -15%
SIA
172
Sit Investment Associates
Minnesota
$1.65M – – –
URS
173
Utah Retirement Systems
Utah
$1.65M – – –
HHC
174
Hutchin Hill Capital
New York
$1.64M +$692K +4,500 +79%
AP
175
Alydar Partners
Massachusetts
$1.61M +$1.54M +10,000 New
5 6
7
8 9

JAZZ Hedge Fund Activity: Q3 2014 in Review

325 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q3 2014, worth a combined $8.58B — up 14% from $7.51B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new JAZZ positions and 44 closed out — a net gain of 21 holders — while 107 added to existing stakes and 118 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $417M. The largest seller was Wells Fargo, cutting an estimated $50.7M.

  • 325 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q3 2014, up from 305 in Q2 2014.
  • Funds reported $8.58B of Jazz Pharmaceuticals stock for Q3 2014, up 14% quarter-over-quarter.
  • 65 funds opened new Jazz Pharmaceuticals positions in Q3 2014 and 44 closed out, a net change of +21 holders.
  • The largest Jazz Pharmaceuticals buyer in Q3 2014 was Fidelity Investments, an estimated $417M added.
  • The largest Jazz Pharmaceuticals seller in Q3 2014 was Wells Fargo, an estimated $50.7M sold.

Based on aggregated 13F filings for Q3 2014.